Discover
GELS
Gelteq Limited
0.55
2 x 0.39
2 x 0.74
bid
ask
-
0.01
1.13%
10:15 AM
timesize
| Ytd | -31.40% | |
| 1y | -56.10% |
0.54
day range
0.55
0.39
52 week range
2.02
| Open | 0.55 | Prev Close | 0.56 | Low | 0.54 | High | 0.55 | Mkt Cap | 5.88M |
| Vol | 1.61K | Avg Vol | 3.62M | EPS | -0.52 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.45 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.60 | 200-d Avg | 0.75 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|